Natera (NTRA) Competitors $160.72 -8.22 (-4.87%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$162.14 +1.41 (+0.88%) As of 07:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NTRA vs. HIMS, GH, OPCH, RDNT, BTSG, SHC, CON, PRVA, SGRY, and WGSShould you be buying Natera stock or one of its competitors? The main competitors of Natera include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), Surgery Partners (SGRY), and GeneDx (WGS). These companies are all part of the "healthcare" industry. Natera vs. Its Competitors Hims & Hers Health Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Concentra Group Holdings Parent Privia Health Group Surgery Partners GeneDx Natera (NASDAQ:NTRA) and Hims & Hers Health (NYSE:HIMS) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership. Does the media favor NTRA or HIMS? In the previous week, Hims & Hers Health had 75 more articles in the media than Natera. MarketBeat recorded 91 mentions for Hims & Hers Health and 16 mentions for Natera. Natera's average media sentiment score of 1.35 beat Hims & Hers Health's score of 0.18 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 11 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 12 Very Positive mention(s) 10 Positive mention(s) 59 Neutral mention(s) 6 Negative mention(s) 3 Very Negative mention(s) Neutral Is NTRA or HIMS more profitable? Hims & Hers Health has a net margin of 9.24% compared to Natera's net margin of -10.36%. Hims & Hers Health's return on equity of 22.75% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-10.36% -18.29% -11.68% Hims & Hers Health 9.24%22.75%15.51% Do analysts prefer NTRA or HIMS? Natera currently has a consensus target price of $184.63, suggesting a potential upside of 14.87%. Hims & Hers Health has a consensus target price of $39.58, suggesting a potential downside of 17.31%. Given Natera's stronger consensus rating and higher probable upside, equities research analysts plainly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 3.00Hims & Hers Health 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92 Which has more volatility and risk, NTRA or HIMS? Natera has a beta of 1.73, suggesting that its share price is 73% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.03, suggesting that its share price is 103% more volatile than the S&P 500. Do insiders & institutionals hold more shares of NTRA or HIMS? 99.9% of Natera shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 7.6% of Natera shares are held by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has better earnings and valuation, NTRA or HIMS? Hims & Hers Health has lower revenue, but higher earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.70B12.93-$190.43M-$1.47-109.33Hims & Hers Health$1.48B7.26$126.04M$0.6969.38 SummaryHims & Hers Health beats Natera on 9 of the 16 factors compared between the two stocks. Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTRA vs. The Competition Export to ExcelMetricNateraMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$23.07B$7.40B$5.48B$8.94BDividend YieldN/A2.79%5.38%4.12%P/E Ratio-109.3328.0626.2119.74Price / Sales12.9332.91395.44109.12Price / CashN/A22.0136.4957.06Price / Book17.766.617.935.37Net Income-$190.43M$230.16M$3.15B$248.34M7 Day Performance-2.10%5.34%0.75%1.67%1 Month Performance0.02%7.07%3.45%4.56%1 Year Performance45.19%36.42%34.85%18.42% Natera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTRANatera2.125 of 5 stars$160.72-4.9%$184.63+14.9%+49.1%$23.07B$1.70B-109.334,434Positive NewsHIMSHims & Hers Health2.1167 of 5 stars$42.09-34.5%$38.00-9.7%+123.5%$9.42B$1.48B61.001,637Trending NewsInsider TradeGap DownHigh Trading VolumeGHGuardant Health3.6171 of 5 stars$48.55-1.2%$53.76+10.7%+79.4%$6.01B$774.00M-14.322,021OPCHOption Care Health4.1209 of 5 stars$31.05-1.5%$35.50+14.3%+16.9%$5.08B$5.19B25.048,088Positive NewsRDNTRadNet4.2205 of 5 stars$54.87-0.7%$69.60+26.8%-5.0%$4.12B$1.83B-127.6011,021Positive NewsAnalyst DowngradeBTSGBrightSpring Health Services1.6013 of 5 stars$22.77+2.2%$24.90+9.4%+103.2%$4.00B$11.27B81.3235,000SHCSotera Health3.0206 of 5 stars$11.09-2.6%$15.80+42.5%-1.1%$3.15B$1.10B138.643,000CONConcentra Group Holdings Parent2.9872 of 5 stars$20.95+1.0%$28.50+36.0%N/A$2.69B$1.90B15.6311,250PRVAPrivia Health Group3.668 of 5 stars$21.61-1.1%$27.77+28.5%+31.8%$2.63B$1.74B180.101,140News CoverageSGRYSurgery Partners2.2958 of 5 stars$20.20+4.7%$33.56+66.1%-3.7%$2.59B$3.11B-13.2015,000WGSGeneDx1.9088 of 5 stars$79.71+19.0%$86.75+8.8%+214.7%$2.27B$305.45M-56.531,200Analyst ForecastHigh Trading Volume Related Companies and Tools Related Companies HIMS Competitors GH Competitors OPCH Competitors RDNT Competitors BTSG Competitors SHC Competitors CON Competitors PRVA Competitors SGRY Competitors WGS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NTRA) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
